HIF1α Activates Glycolysis to Suppress Mycobacterium tuberculosis Growth in Mouse Bone Marrow‐Derived Macrophages

Immunology · Published 2026-02-08 · DOI 10.1111/imm.70116

Authors being retrieved — see the publisher record. https://doi.org/10.1111/imm.70116

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

HIF-1α-centered metabolic reprogramming in osteoarthritis: cell type-specific effects and intercellular crosstalk among chondrocytes, BMSCs, and macrophages · Frontiers in Immunology · 2026 · Cites or is cited by this article
STAT2 Mediated Epigenetic and Epitranscriptomic Regulation of CD4 + T Helper Cell Differentiation in Non‐Small Cell Lung Cancer ( NSCLC ) · Immunology · 2026 · Same journal
Strategies of AI ‐Driven CAR ‐T Cell Therapy Towards Solid Tumours · Immunology · 2026 · Same journal
Epigenetic Gene Networks Governing Immune State Transitions Across the Lifespan · Immunology · 2026 · Same journal
Precision Glyco‐Modulated GcMAF2.0 Targets CLEC10A to Bidirectionally Re‐Wire Macrophage States: Cross‐Species Evidence, Mechanistic Omics and Translational Horizons · Immunology · 2026 · Same journal
Methionine Regulates Antitumour Function of CD8 + T Cells Through Polyamine Synthesis · Immunology · 2026 · Same journal
MyD88 ‐Family Adaptors: Compartmentalised Signalling and Non‐Immune Functions · Immunology · 2026 · Same journal
Dual Functions of Treg in the Mucosal Barrier and Lung Cancer Microenvironment and Prospects for Targeted Therapy · Immunology · 2026 · Same journal
Epidermal Dominance of Metabolically Constrained Immune Niches Underpins Immune Activation Signatures and Clinical Severity in Psoriatic Disease · Immunology · 2026 · Same journal
IL ‐6/ IL ‐ 6R ‐Mediated Mechanisms in Lung Cancer: From Pathogenesis to Potential Therapeutic Targets · Immunology · 2026 · Same journal